Support in USA : 1-978- 707-9553 / Support in India : +91- 9987711567

  • Apple Pharmaceuticals

Efavir

HIV-AIDS-Cipla-Efavirenz-600mg-Efavir

Availability: In stock

Special Price $ 50

BRAND : Efavir
STRENGTH : 600mg
INGREDIENT : HIV-AIDS-Cipla-Efavirenz-600mg-Efavir
COMPANY NAME : Cipla
COUNT : 30 Tablets



Description of Efavir

PRODUCT SPECIFICATION Brand Name : EFAVIR Active ingredient: Efavirenz Manufactured by : Cipla Ltd. Strength : 600mg Dosage Form : Tablets Packing : Pack of 30 Tablets ABOUT EFAVIR Efavir tablet in co administration with other drugs to treat the infection caused by HIV. Efavir will not curable or preventable HIV/AIDS. Efavir suppress the HIV replication of virus cell and despite the destruction of the immune system. Efavir may help to delay the problems arises from AIDS/HIV diseases. The medicine allowed to purchase only with doctors prescription.

Pharmacology of Efavir

PHARMACOLOGY PHARMACODYNAMIC MECHANISM OF ACTION: Efavi is an non nucleoside reverse transcriptase inhibitor that fight against HIV-1 and stops HIV-1 replication and RNA & DNA dependent polymerase activities. PHARMACOKINETIC ABSORPTION: Efavirenz (Efavir) , bioavailabilty is 42% and Peak plasma concentration is 3-5hr. DISTRIBUTION:. Efavirenz (Efavir) is distributed in CSF, enter into breast milk and protein bound is 99% METABOLISM: Efavirenz (Efavir) mainly metabolized inCYP3A4 and CYP2B and isoenzyme to inactive hydroxyl metabolite. ELIMINATION: In Efavir excreted via urine(14-34%) and faeces is 16-61% while terminal half life is 52-76hr(single dose) and 40-55hr (multiple dose).

Indication of Efavir

In adult and childerns 3 months old / weight of 3.5kg, Efavir is used by combination with other antiretroviral regimens for the treatment of HIV-1 type(human immunodeficiency virus).

Dose & Dosage's of Efavir

Efavir co administration with other antiretrovirals dosage of 600mg once daily (capsule/tablet) and solution of 720mg once daily. Efavir should administrated with empty stomach, preferably bedtime.

Side Effects of Efavir

Rash and erythema multiforme CNS effects like dizziness, headache, insomnia, somnolence, abnormal dreams, fatigue, impaired concentration. Nausea, less frequently, vomiting, diarrhoea, hepatitis, depression, anxiety, psychosis, amnesia and ataxia, stupor, abdominal pain, liver failure, pancreatitis, convulsions, gynaecomastia, pruritus, blurred vision.

Contraindication of Efavir

Concurrent use with terfenadine, astemizole, cisapride, midazolam, triazolam, pimozide, bepridil or ergot alkaloids (ergotamine) causes hypersensitivity, severe hepatic impairment, lactation in patient.

Drug Interaction of Efavir

Efavir with psychoactive drugs leads to additive CNS effects and change plasma warfarin concentrations with warfarin. Interaction with HIV integrase inhibitors (dolutegravir), other HIV NNRTIs ( etravirine), HMG-CoA reductase inhibitors ( simvastatin) reduce plasma concentration Efavir with voriconazole ,plasma concentrations of efavirenz is high and voriconazole is decreased when given continusily. Serious, life-threatening events (e.g. cardiac arrhythmias, respiratory depression) may produce when Efavir given with terfenadine, astemizole, cisapride, midazolam, triazolam, pimozide, bepridil or ergot alkaloids (ergotamine)

Precaution of Efavir

Monitor the patients with these problems and inform the healthcare providers: * cholesterol and triglycerides. * LFTs in patients with history of hepatitis B and/or C.Hepatic Function Use. * Convulsions Use with caution in patients with history of seizures.. * CNS symptoms * Redistribution/accumulation of body fat, including central obesity, dorsocervical fat enlargement, peripheral wasting, facial wasting, breast enlargement.. * Liver enzymes in patients with suspected past of hepatitis B or C infection and liver toxicity. * Immune reconstitution syndrome . Lipids Increases in total cholesterol and triglycerides have been checked, Monotherapy Resistant virus may emerge rapidly. * Psychiatric symptoms psychiatric disorders may be at greater risk. There have been occasional reports of death by suicide, delusions, and psychosis-like behavior. * Skin rash Reported in 26% of adults and 46% of children. * Overdosage Symptoms Increased CNS symptoms, involuntary muscle contractions.

Usage & Safety profile of Efavir Pregnancy & Lactation

Efavirenz has category D: Based on adverse effects by investigation and experience studies in humans a positive identification of human fetal risk is reported.

Storage of Efavir

Efavir store in a closed container at room temperature, kept away the medicine (Efavir) from heat, moisture, and direct light. Keep from freezing and reach of children. Do not use after expiry date. Ask your consultant about how should dispose of any medicine you do not use .